NICE Conference 2026 sponsors
Dexcom
From data to decisions: the role of real-world evidence (RWE) in NICE's healthtech assessment
Dexcom will be hosting an invitation only lunchtime roundtable between 12:15pm and 1:20pm in meeting rooms 8 - 9. The topic of the roundtable will be From data to decisions: the role of real-world evidence (RWE) in NICE's healthtech assessment.
By invitation only.
Roundtable lunch
Dexcom will be hosting an “invitation-only” lunchtime roundtable at the conference between 12.15pm to 1.20pm in meeting rooms 8 and 9.
The topic of the roundtable will be: From data to decisions: the role of real-world evidence in NICE’s medical technology assessment.
If you are attending the NICE Conference 2025 and would like to be considered for an invitation to this roundtable, please email your request to NICE@dods-events.com.
AscellaHealth
Sponsor of the networking lunch in the Podium restaurant
AscellaHealth partners with life sciences manufacturers around the world, enabling them to successfully commercialise therapies for complex, chronic conditions. Our comprehensive suite of services guides clients through every stage of the process, from clinical trials through approval, pre-commercialisation support, and ultimately transitioning patients on to therapy.
Our global expertise in specialty fulfilment, data analytics, and patient support/HUB services allows us to streamline product launch, provide an ecosystem of financial support to our partners, and ensure patients have access to therapies they need for better outcomes.
Exhibitors
The following organisations will be exhibiting at the NICE Conference 2026.
Ardens
Ardens enables efficient data recording, reporting, and analysis for primary care. With clinical decision support from Ardens Clinical and advanced analytics from Ardens Manager, organisations can enhance patient care, optimise workflows, prioritise activity, streamline contract management, maximise income, and save time and resource through standardised, data-driven insights.
X: @Ardens_Health
AXIS Reimbursement Experts
AXIS is a specialist boutique consultancy with 14 years of experience in strategic market access and Health Technology Assessments (HTA). AXIS is driven by a commitment to improving patient access to vital treatments. By combining technical expertise, strategic insight, and deep knowledge of HTA processes across the UK and Ireland, AXIS ensures efficient reimbursement pathways for clients.
Decisive Consulting, a Herspiegel company
Decisive Consulting Ltd was established in 2020 to assist pharmaceutical companies to navigate the complex landscape of market access, driven by a core belief that Patient Access is everyone’s business. By taking an “access first” lens to the development of projects and commercial strategy, we enable our clients to plan for what matters most – making sure promising technologies and treatments reach those they are designed to support as early as possible following diagnosis.
Harnessing our team of experts with extensive cross-functional international experience in the pharmaceutical industry and an incredible network of skilled professionals and partners, we bring the curiosity, capability, and capacity our clients need at “Decisive Moments” of their evolution where and when they need it. Identifying those decisive moments, and working together to build a deep understanding, we provide support, challenge and a different “rebel” perspectives to our clients.
We believe that our focus on the “what” and the “how” is one of the aspects that sets us apart. We guide our clients in implementing plans and programmes as well as developing the core strategies that drive them, aiming to enable better decision making and to leave our clients well equipped for what comes next.
bioMérieux
bioMérieux is committed to improving public health and supporting healthcare providers by addressing critical issues like sepsis, antimicrobial resistance, and respiratory infections. Our high medical value diagnostics provide clear and actionable results that empower teams in making timely informed decisions, leading to better patient outcomes and healthcare resource use.
X: @biomerieux
Dendrite Clinical Systems
Dendrite Clinical Systems is a global provider of clinical databases and data analysis/reporting software for hospitals and national/international clinical registries.
Dendrite provides Data and Audit platforms to numerous Surgical Societies, Charities, Commissioning and commercial organisations including synoptic on-line dashboards.
Evondos
Evondos is a medication dispensing robot that reminds you of the time to take your dose, provides valuable guidance and acts as a locked medicine cabinet when medication is missed.
Care providers can monitor the activity of the Evondos robot remotely and refill the robot with medication, ensuring safety at all times.
X: @evondos
HACT
HACT partners with organisations to drive value for communities through pioneering insight-led products, sector-specific tools, and services. Services include:
- calculating your social impact
- demonstrating the value of community investment
- enhancing success via our networks and Centre for Excellence in Community In-vestment
- generating additional revenue for your retrofit activity
X: @HACThousing
Lyfegen
Lyfegen provides rebate management software for healthcare, enabling insurers, governments, and pharma to streamline complex drug pricing agreements, optimize rebates, and access the world’s largest repository of pricing models.
Headquartered in Switzerland, Lyfegen operates globally with solutions that reduce administrative burdens and improve value. Learn more at Lyfegen.com.
National Institute for Health and Care Research | NIHR
The NIHR is funded by the Department of Health and Social Care to improve the health and wealth of the nation through research.
Working in partnership with the NHS, universities, local government, other research funders, patients and the public – we fund, enable and deliver world-leading health and social care research that improves people’s health and wellbeing and promotes economic growth.
X: @NIHRresearch
NHS Blood and Transplant
NHS Blood and Transplant is a special health authority that provides a blood and transplantation service to the NHS, looking after blood donation services in England and transplant services across the UK. This includes managing the donation, storage and transplantation of blood and blood components, organs, tissues, bone marrow and stem cells, and researching new treatments and processes. Our mission is to save and improve lives through our work.
Each day we need around 5000 donations so, with the support of our amazing donors, we give a lifeline to thousands of people every year.
X: @NHSBT
Health Technology Wales
Health Technology Wales (HTW) produces national guidance on non-medicine health and care technologies. The organisation is funded by Welsh Government and hosted by Velindre University NHS Trust but is independent of both. It carries out health technology assessments of health and care technologies and publishes national guidance on their use in Wales.
Twitter: @HealthTechWales
Lyfegen
Lyfegen offers solutions for the healthcare industry to identify the right drug pricing agreements, simulate and understand the financial impacts of those agreements, and automate the execution and adjudication of them—thus delivering a measurable reduction in administrative effort in rebate management and optimization.
Event supporters
Our thanks to the following event supporters who have assisted us in marketing this event to their members but have had no direct input into the content of the event.
The Association of British HealthTech Industries
ABHI is the UK’s leading industry association for health technology (HealthTech). ABHI supports the HealthTech community to save and enhance lives. Members, including both multinationals and small and medium sized enterprises (SMEs), supply products from syringes and wound dressings to surgical robots, diagnostics and digitally enhanced technologies. We represent the industry to stakeholders, such as the government, NHS and regulators.
HealthTech plays a key role in supporting delivery of healthcare and is a significant contributor to the UK’s economic growth. HealthTech is the largest employer in the broader Life Sciences sector, employing 154,000 people in 4,465 companies, with a combined turnover of £34.3bn. The industry has enjoyed growth of around 5% in recent years. ABHI’s 400 members account for approximately 80% of the sector by value.
The Association of the British Pharmaceutical Industry
The ABPI exists to make the UK the best place in the world to research, develop and access medicines and vaccines to improve patient care.
We represent companies of all sizes which invest in making and discovering medicines and vaccines to enhance and save the lives of millions of people around the world.
In England, Scotland, Wales and Northern Ireland, we work in partnership with governments and the NHS so that patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, our members partner with healthcare professionals, academics and patient organisations to find new solutions to unmet health needs.
The BioIndustry Association
The BioIndustry Association (BIA) is the voice of the innovative life sciences and biotech industry, enabling and connecting the UK ecosystem so that businesses can start, grow and deliver world-changing innovation.
We are an award-winning trade association representing more than 600 member companies including:
• Start-ups, biotechnology and innovative life science companies
• Pharmaceutical and technological companies
• Universities, research centres, tech transfer offices, incubators and accelerators
• A wide range of life science service providers: investors, lawyers, IP consultants and IR agencies
Explore opportunities to influence, connect and save with the BIA.
The Medical Technology Group
The Medical Technology Group (MTG) is the only UK coalition of patient groups, research charities, trade associations, medical technology and life sciences companies working together to improve patient access to medical technologies.
The MTG has over 50 members, representing a diverse range of clinical, technological and therapeutic areas.